Neostigmine Methylsulfate
- Product NDC
- 76045-214
- 11-digit product format
- 760450214
- Labeler code
- 76045
- Product ID
- 76045-214_27e94d4f-f8d8-437a-a770-7020a9f8f61d
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Neostigmine Methylsulfate
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Fresenius Kabi USA, LLC
- Application
- NDA203629
- Marketing category
- NDA
- Marketing start
- 2018-09-18
- Substance
- NEOSTIGMINE METHYLSULFATE
- Active strength
- 1 mg/mL
- Pharmacologic classes
- Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| 98IMH7M386 | NEOSTIGMINE METHYLSULFATE | 51-60-5 | NEOSTIGMINE METHYLSULFATE |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 76045-214-30 | 76045021430 | 10 BLISTER PACK in 1 CARTON (76045-214-30) / 1 SYRINGE, GLASS in 1 BLISTER PACK (76045-214-00) / 3 mL in 1 SYRINGE, GLASS | 10 blister pack | 2022-06-01 | No | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| Neostigmine Methylsulfate | Fresenius Kabi USA, LLC | 2024-01-01 | HUMAN PRESCRIPTION DRUG LABEL | 16 |